"Doomsday indicator” flashing for the first time since the Great Depression...

It's been a bloodbath in the markets. The seven most valuable US tech companies lost a combined $1 trillion - in a single day. And things could get a lot worse...

Click here to discover how Wall Street insiders are quietly preparing for a market crash >>>

Brian Lian Biography and Net Worth

CEO of Viking Therapeutics

Dr. Lian serves as our President and Chief Executive Officer, and as a director. Prior to founding Viking Therapeutics, he was a Managing Director and Senior Research Analyst at SunTrust Robinson Humphrey, where he was responsible for coverage of small and mid-cap biotechnology companies with an emphasis on the diabetes, oncology, infectious disease, and neurology spaces. Prior to SunTrust Robinson Humphrey, he was an Executive Director and Senior Biotechnology Analyst at CIBC World Markets, responsible for coverage of mid and small-cap biopharmaceutical companies. Prior to his career in equity research, he was a research scientist in small molecule drug discovery at Amgen, focused on cancer and endocrine diseases. Prior to Amgen, he was a research scientist at Microcide Pharmaceuticals. Dr. Lian holds an MBA in accounting and finance from Indiana University, an M.S. and Ph.D. in organic chemistry from The University of Michigan, and a BA in chemistry from Whitman College.

What is Brian Lian's net worth?: The estimated net worth of Brian Lian is at least $157.14 million as of August 21st, 2024. Dr. Lian owns 2,354,927 shares of Viking Therapeutics stock worth more than $157,144,279 as of September 16th. This net worth evaluation does not reflect any other assets that Dr. Lian may own. Additionally, Dr. Lian receives an annual salary of $987,100.00 as CEO at Viking Therapeutics. Learn More about Brian Lian's net worth.
How old is Brian Lian?: Dr. Lian is currently 58 years old. There are 3 older executives and no younger executives at Viking Therapeutics. Learn More on Brian Lian's age.
What is Brian Lian's salary?: As the CEO of Viking Therapeutics, Inc., Dr. Lian earns $987,100.00 per year. Learn More on Brian Lian's salary.
How do I contact Brian Lian?: The corporate mailing address for Dr. Lian and other Viking Therapeutics executives is 12340 EL CAMINO REAL SUITE 250, SAN DIEGO CA, 92130. Viking Therapeutics can also be reached via phone at (858) 704-4660 and via email at [email protected]. Learn More on Brian Lian's contact information.
Has Brian Lian been buying or selling shares of Viking Therapeutics?: During the last quarter, Brian Lian has sold $14,167,907.22 in shares of Viking Therapeutics stock. Most recently, Brian Lian sold 1,000 shares of the business's stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $69.90, for a transaction totalling $69,900.00. Following the completion of the sale, the chief executive officer now directly owns 2,354,927 shares of the company's stock, valued at $164,609,397.30. Learn More on Brian Lian's trading history.
Who are Viking Therapeutics' active insiders?: Viking Therapeutics' insider roster includes Matthew Foehr (Director), Brian Lian (CEO), Lawson Macartney (Director), Marianna Mancini (COO), Sarah Rouan (Director), Charles Rowland, Jr. (Director), J. Matthew Singleton (Director), Greg Zante (CFO), Greg Zante (CFO), and Greg Zante (CFO). Learn More on Viking Therapeutics' active insiders.
Are insiders buying or selling shares of Viking Therapeutics?: In the last year, insiders at the biotechnology company sold shares 14 times. They sold a total of 1,012,501 shares worth more than $54,639,024.05. The most recent insider tranaction occured on August, 21st when CEO Brian Lian sold 1,000 shares worth more than $69,900.00. Insiders at Viking Therapeutics own 4.7% of the company. Learn More about insider trades at Viking Therapeutics.
Information on this page was last updated on 8/21/2024.

Brian Lian Insider Trading History at Viking Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/21/2024	Sell	1,000	$69.90	$69,900.00	2,354,927
8/19/2024	Sell	112,870	$65.80	$7,426,846.00	2,354,927
7/30/2024	Sell	115,859	$57.58	$6,671,161.22	2,354,927
2/8/2024	Sell	269,079	$26.87	$7,230,152.73	2,184,882
1/30/2024	Sell	35,000	$23.95	$838,250.00	2,264,882
5/1/2023	Sell	45,000	$22.45	$1,010,250.00	2,197,963
4/19/2023	Sell	35,000	$21.45	$750,750.00	2,242,963
4/17/2023	Sell	155,000	$20.45	$3,169,750.00	2,277,963
4/13/2023	Sell	79,336	$18.45	$1,463,749.20	2,307,963
4/3/2023	Sell	22,000	$17.85	$392,700.00	2,232,963
3/31/2023	Sell	67,970	$17.45	$1,186,076.50	2,254,963

Brian Lian Buying and Selling Activity at Viking Therapeutics

Viking Therapeutics Company Overview

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

Today's Range

Now: $67.18

$64.54

$68.83

50 Day Range

MA: $58.00

$49.84

$66.73

2 Week Range

Now: $67.18

$8.28

$99.41

Volume

2,251,866 shs

Average Volume

4,548,935 shs

Market Capitalization

$7.44 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

"Doomsday indicator” flashing for the first time since the Great Depression...

From Behind the Markets | Ad

It's been a bloodbath in the markets. The seven most valuable US tech companies lost a combined $1 trillion - in a single day. And things could get a lot worse...

Click here to discover how Wall Street insiders are quietly preparing for a market crash >>>

Brian Lian Biography and Net Worth

What is Brian Lian's net worth?

How old is Brian Lian?

What is Brian Lian's salary?

How do I contact Brian Lian?

Has Brian Lian been buying or selling shares of Viking Therapeutics?

Who are Viking Therapeutics' active insiders?

Are insiders buying or selling shares of Viking Therapeutics?